Clinical Trial Update: A Single-arm, Multicenter, Prospective Clinical Study of Mitoxantrone Liposome Combined With Chidamide and Azacitidine in the Treatment of Relapsed and Refractory Peripheral T-cell Lymphoma [Phase 2]

View source ↗

Summary

A Phase 2 single-arm multicenter study evaluating mitoxantrone liposome in combination with chidamide and azacitidine for relapsed/refractory peripheral T-cell …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peripheral T-cell Lymphoma

Drugs mentioned

• AZACITIDINE (AZACITIDINE)
• Chidamide (chidamide)
• Mitoxantrone Liposome (mitoxantrone liposome)

Snippet

Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University | Conditions: Peripheral T Cell Lymphoma | Phase 2 | Status: UNKNOWN